Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Surgopaedia
Search
Search
Appearance
Create account
Log in
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Editing
Hepatocellular carcinoma
(section)
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== '''Transplant for HCC''' === * Theoretically the perfect treatment because it fixes the HCC and the underlying cirrhosis * Gold standard for patients with CP-B/C cirrhosis and limited hepatic reserve * Downsides - limited donor organ availability, long wait times can lead to progression or drop-out * '''Indications:''' ** '''Consider in:''' *** CP B or C cirrhosis, or portal hypertension *** Early-stage HCC *** No extrahepatic disease or macrovascular invasion ** Previously '''Milan criteria for transplant eligibility''' - eligible if: *** Single tumours <=5cm OR *** up to 3 tumours, largest of which is <=3cm ** Now '''Metroticket 2.0 additional criteria''' *** General AFP cut-off <1000 *** No macrovascular invasion, no extrahepatic spread *** Can be down-staged to meet criteria * While awaiting transplant, can control progression with ablation/trans-arterial therapy * Histological information is actually very useful in prognosticating, but is not often available, due to risk of seeding from biopsy. * 5-year overall survival 84%, 9% HCC recurrence * If patients present beyond Milan criteria, they can be down-staged with RFA/TACE/TARE and then transplanted with similar outcomes to those that present within criteria * MELD score - originally developed to predict mortality of patients undergoing TIPS, but can be used to generalise how sick a patient is and is also used to allocate livers on transplant list.
Summary:
Please note that all contributions to Surgopaedia may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Surgopaedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Hepatocellular carcinoma
(section)
Add topic